JOHNSON FRANKLIN P JR 4
4 · AMGEN INC · Filed Feb 4, 2005
Insider Transaction Report
Form 4
AMGEN INCAMGN
JOHNSON FRANKLIN P JR
Director
Transactions
- Sale
Common Stock
2005-02-03$62.42/sh−9,400$586,748→ 610,000 total(indirect: By Partnership) - Sale
Common Stock
2005-02-03$62.00/sh−7,500$465,000→ 626,900 total(indirect: By Partnership) - Sale
Common Stock
2005-02-03$62.43/sh−10,000$624,300→ 600,000 total(indirect: By Partnership)
Footnotes (1)
- [F1](FPJ 2.03.05) Does not include (i) 898,622 shares held directly by the reporting person, (ii) 4 units contractual contingent payment rights held as indirect ownership by Asset Management Partners (the "Partnership") arising from the purchase by Amgen Inc of two Class A interests of Amgen Clinical Partners, L.P., and (iii) 822,888 Shares held as indirect ownership by reporting person's spouse. The reporting person disclaims beneficial ownership of the securities held by the Partnership and the securities held by the reporting person's spouse and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 of the Securities Exchange Act of 1934.